Drug Shortage Report for ASATAB EC 325MG
| Report ID | 1390 |
| Drug Identification Number | 02352427 |
| Brand name | ASATAB EC 325MG |
| Common or Proper name | Acetylsalicylic Acid Delayed Release Tablets, USP |
| Company Name | ODAN LABORATORIES LTD |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | ACETYLSALICYLIC ACID |
| Strength(s) | 325MG |
| Dosage form(s) | TABLET (DELAYED-RELEASE) |
| Route of administration | ORAL |
| Packaging size | 100; 1000 |
| ATC code | N02BA |
| ATC description | OTHER ANALGESICS AND ANTIPYRETICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2016-04-15 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2017-10-05 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | info@odanlab.com Tel.: 1-800-387-9342 Fax: 1-800-329-6326 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2017-03-13 | French | Compare |
| v1 | 2017-03-13 | English | Compare |
Showing 1 to 2 of 2